Table 3. Medication use for Dose-Response to Exercise in Women Aged 45 to 75 Years (DREW) study participants.
Medication | All (n) | Exercise Treatment Group (n) | |||
---|---|---|---|---|---|
|
|||||
Control | 4 KKW | 8 KKW | 12 KKW | ||
Blood pressure | |||||
Baseline | 113 (28) | 22 (24) | 37 (26) | 26 (31) | 28 (30) |
Follow-up | 108 (28) | 20 (24) | 37 (29) | 29 (36) | 22 (25) |
Antidepressant | |||||
Baseline | 75 (18) | 14 (16) | 26 (19) | 16 (19) | 19 (20) |
Follow-up | 71 (19) | 16 (19) | 24 (19) | 14 (17) | 17 (20) |
Cholesterol | |||||
Baseline | 64 (16) | 14 (16) | 27 (19) | 13 (15) | 10 (11) |
Follow-up | 57 (15) | 14 (17) | 22 (17) | 13 (16) | 8 (9) |
Glucose regulation | |||||
Baseline | 2 (1) | 1 (1) | 0 (0) | 0 (0) | 1 (1) |
Follow-up | 4 (1) | 1 (1) | 1 (1) | 1 (1) | 1 (1) |
Thyroid | |||||
Baseline | 62 (15) | 14 (16) | 17 (12) | 14 (17) | 17 (18) |
Follow-up | 53 (14) | 12 (14) | 14 (11) | 13 (16) | 14 (16) |
Current hormonal therapy | |||||
Baseline | 183 (45) | 47 (52) | 58 (41) | 35 (41) | 43 (46) |
Follow-up | 152 (37) | 38 (42) | 47 (34) | 31 (37) | 36 (39) |
Data in parentheses are percentages.